Semaglutide is an FDA-approved medication that mimics the GLP-1 hormone, which regulates blood sugar levels and appetite
El seguimiento debe incluir monitoreo de HbA1c cada 3 meses inicialmente, evaluacin de peso y efectos adversos en cada visita, y funcin renal peridicamente
These conditions are increasingly prevalent in women, particularly after the menopause
Official company medical information page
Benefits at a glance: Tirzepatide/Cyanocobalamin - Effective in reducing HbA1c levels, a measure of long-term blood sugar control - Promotes significant weight loss, which is beneficial for individuals with obesity or overweight - Improves insulin sensitivity, leading to better glycemic control - Reduces the risk of cardiovascular events, such as heart attacks or strokes - Convenient once-weekly dosing, providing convenience and adherence to treatment - Demonstrates superior glycemic control compared to other diabetes medications, ensuring better blood sugar management - Well-tolerated with manageable side effects, enhancing patient compliance and satisfaction - Shows promise in reducing liver fat and improving liver health, which can have significant implications for individuals with fatty liver disease or non-alcoholic steatohepatitis (NASH).